Mettler-Toledo International, Inc. (MTD) · page 85 of 136
The slide uses a table to demonstrate that Biotix revenue significantly underperformed the $35m run rate cited at acquisition, leading to a one-time gain reversal.
Activist deck · expose_contradiction · expose_contradiction · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
callout 2/2 paragraph 1/1 source-note 1/1 table 1/1 title 1/1
Components 6
primary primary paragraph source-note data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1